XML 62 R42.htm IDEA: XBRL DOCUMENT v3.25.0.1

Segment Information (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Net Sales and Operating Profit by Segment

			2024
			Net sales			Cost of Sales			Selling, general and administrative expenses			Other (income) expense, net (3)			Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America(1)			$	4,113		$	1,571		$	1,668		$	36		$	839
Latin America			4,782			1,933			1,328			(5)			1,526
Europe			2,770			1,050			1,031			31			658
Asia Pacific			2,858			1,078			997			(30)			812
Africa/Eurasia			1,095			432			395			16			253
Total Oral, Personal and Home Care			15,618												4,088
Pet Nutrition(2)			4,483			1,869			1,641			8			965
Reconciliation with Total Company Operating Profit
Corporate															(784)
Total			$	20,101											$	4,268

Note: Table may not sum due to rounding.

(1) Net sales in the U.S. for Oral, Personal and Home Care were $3,640 in 2024.

(2) Net sales in the U.S. for Pet Nutrition were $3,059 in 2024.

(3) Refer to Note 16, Supplemental Income Statement for information related to Other (income) expense, net.

			2023
			Net sales			Cost of Sales			Selling, general and administrative expenses			Other (income) expense, net (3)			Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America(1)			$	4,091		$	1,588		$	1,594		$	37		$	871
Latin America			4,640			1,977			1,241			5			1,417
Europe			2,571			1,069			899			31			573
Asia Pacific			2,782			1,108			925			(18)			767
Africa/Eurasia			1,083			442			377			9			254
Total Oral, Personal and Home Care			15,167												3,882
Pet Nutrition(2)			4,290			1,964			1,493			26			806
Reconciliation with Total Company Operating Profit
Corporate															$	(704)
Total			$	19,457											$	3,984

Note: Table may not sum due to rounding.

(1) Net sales in the U.S. for Oral, Personal and Home Care were $3,625 in 2023.

(2) Net sales in the U.S. for Pet Nutrition were $2,918 in 2023.

(3) Refer to Note 16, Supplemental Income Statement for information related to Other (income) expense, net.

			2022
			Net sales			Cost of Sales			Selling, general and administrative expenses			Other (income) expense, net (3)			Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America(1)			$	4,002		$	1,649		$	1,567		$	46		$	741
Latin America			3,982			1,885			1,059			(71)			1,108
Europe			2,362			1,023			778			28			534
Asia Pacific			2,826			1,160			954			(24)			737
Africa/Eurasia			1,082			447			389			18			228
Total Oral, Personal and Home Care			14,254												3,348
Pet Nutrition(2)			3,713			1,569			1,287			7			850
Reconciliation with Total Company Operating Profit
Corporate															$	(1,305)
Total			$	17,967											$	2,893

Note: Table may not sum due to rounding.

(1) Net sales in the U.S. for Oral, Personal and Home Care were $3,511 in 2022.

(2) Net sales in the U.S. for Pet Nutrition were $2,432 in 2022

(3) Refer to Note 16, Supplemental Income Statement for information related to Other (income) expense, net.

						2024						2023						2022
Capital expenditures
Oral, Personal and Home Care
North America						$	52					$	46					$	66
Latin America						126						146						121
Europe						63						44						31
Asia Pacific						64						65						60
Africa/Eurasia						12						10						30
Total Oral, Personal and Home Care						317						311						308
Pet Nutrition						143						301						297
Corporate						101						93						91
Total Capital expenditures						$	561					$	705					$	696

						2024						2023						2022
Depreciation and amortization
Oral, Personal and Home Care
North America						$	124					$	116					$	128
Latin America						100						98						93
Europe						65						65						68
Asia Pacific						81						84						89
Africa/Eurasia						8						9						9
Total Oral, Personal and Home Care						378						372						387
Pet Nutrition						132						101						65
Corporate						95						94						93
Total Depreciation and amortization						$	605					$	567					$	545

						2024						2023
Long-lived assets(1)
United States						$	2,728					$	2,733
International						2,223						2,340
Total Long-lived assets						$	4,951					$	5,073

(1) Long-lived assets include Property, plant and equipment, net and lease right-of-use assets.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration